drugset / Trial / NCT01355016

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers

NCT01355016 ↗

Phase 1 Completed 48 enrolled MicroDose Therapeutx, Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the range of single inhaled doses of a new dry powder product, MDT-637, that are safe and well-tolerated. This includes monitoring effects on pulmonary function and determination of blood levels of MDT-637 following inhalation.

Timeline

Start
2011-09
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject VP-14637 Small molecule — Inhaled